REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

"Merck" Sp. z o.o. (Poland)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: "Merck" Sp. z o.o. Profile Updated: October 12, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Merck Ltd. is a division of a global pharmaceutical and chemicals company and supplies to the Polish market of high quality pharmaceutical and chemical products.

Headquarters
Ul. Al. Aleje Jerozolimskie 142B
Warsaw; Mazowieckie; Postal Code: 02-305

Contact Details: Purchase the "Merck" Sp. z o.o. report to view the information.

Website: http://www.merck.pl

Basic Information
Total Employees:
Purchase the "Merck" Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the "Merck" Sp. z o.o. report to view the information.
Registered Capital:
Purchase the "Merck" Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the "Merck" Sp. z o.o. report to view the information.
Incorporation Date:
April 09, 2001
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Proxy
Purchase this report to view the information.
Proxy
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Merck Life Science Sp. z o.o.
100%
Company Performance
Financial values in the chart are available after "Merck" Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
5.96%▲
Total operating revenue
6.08%▲
Operating profit (EBIT)
132.21%▲
EBITDA
120.65%▲
Net Profit (Loss) for the Period
83.1%▲
Total assets
3.38%▲
Total equity
5.33%▲
Operating Profit Margin (ROS)
1.66%▲
Net Profit Margin
0.61%▲
Return on Equity (ROE)
2.15%▲
Debt to Equity Ratio
-0.07%▼
Quick Ratio
0.2%▲
Cash Ratio
0.12%▲

Similar companies

Neuca S.A.
 
"Farmacol" S.A.
Polska Grupa Farmaceutyczna S.A.
 
Zaklady Farmaceutyczne "Polpharma" S.A.
Urtica Sp. z o.o.
 
Essity Poland Sp. z o.o.
Pgd Polska Sp. z o.o.
 
Novo S.A.
Astellas Pharma Sp. z o.o.
 
"Pfizer Trading Polska Sp. z o.o."
"Medivet" S.A.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo